CYTOMX THERAPEUTICS INC. - COMMON STOCK
2.1250
27-May-25 13:00:13
15 minutes delayed
Stocks
-0.1050
-4.71%
Today's range
2.1000 - 2.2981
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: CYTOMX THERAPEUTICS INC. - COMMON STOCK
25 Oct 2024 08:27:19 By NetDania Notify
-
09 Sep 2024 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming September Investor Conferences
04 Sep 2024 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
08 Aug 2024 13:10:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
01 Aug 2024 05:00:00 By Nasdaq GlobeNewswire
-
18 Jun 2024 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
17 Jun 2024 13:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
22 May 2024 13:05:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Announces New Employment Inducement Grants
16 May 2024 13:15:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
08 May 2024 13:10:00 By Nasdaq GlobeNewswire
-
08 May 2024 13:10:00 By Nasdaq GlobeNewswire
-
07 May 2024 13:15:00 By Nasdaq GlobeNewswire
-
01 May 2024 05:00:00 By Nasdaq GlobeNewswire
-
08 Apr 2024 05:00:00 By Nasdaq GlobeNewswire
-
03 Apr 2024 05:00:01 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors
21 Mar 2024 05:00:00 By Nasdaq GlobeNewswire
-
18 Mar 2024 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
11 Mar 2024 13:10:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
04 Mar 2024 05:00:00 By Nasdaq GlobeNewswire
-
CytomX Therapeutics to Present at Upcoming March Investor Conferences
27 Feb 2024 05:00:00 By Nasdaq GlobeNewswire